Company: BIAF
Filing Date: 2025-04-11
Form Type: S-1
Source: 0001641172-25-003892
Chunk: 70

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-11
Form: S-1
Chunk 70
---
 determines we are in compliance and the matter
will be closed; however, Nasdaq may require the closing bid price to equal or to exceed the $1.00 minimum bid price requirement for more
than 10 consecutive business days before determining that a company complies.

If, however, we do not achieve compliance with the
Minimum Bid Price Requirement by August 6, 2025, we may be eligible for additional time to comply. In order to be eligible for such additional
time, we will be required to meet the continued listing requirements for market value of publicly held shares and all other initial listing
standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and must notify Nasdaq in writing of
our intention to cure the deficiency during the second compliance period. We intend to actively monitor the bid price of our Common Stock
and will consider available options to regain compliance with the Nasdaq listing requirements.

| 30 |

If we fail to satisfy the continued listing requirements
of The Nasdaq Capital Market, such as the corporate governance requirements, the stockholder’s equity requirement, or the minimum
closing bid price requirement, The Nasdaq Capital Market may take steps to de-list our Common Stock or Tradeable Warrants. Such a de-listing
or even notification of failure to comply with such requirements would likely have a negative effect on the price of our Common Stock
and Tradeable Warrants and would impair the ability to sell or purchase our Common Stock when you wish to do so. In the event of a de-listing,
we would take actions to restore our compliance with The Nasdaq Capital Market’s listing requirements, but we can provide no assurance
that any such action taken by us would allow our Common Stock to become listed again, stabilize the market price, improve the liquidity
of our Common Stock, prevent our Common Stock from dropping below The Nasdaq Capital Market minimum bid price requirement, or prevent
future non-compliance with The Nasdaq Capital Market’s listing requirements.

The National Securities Markets Improvement Act of
1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to
as “covered securities.” Because our Common Stock is listed on The Nasdaq Capital Market, it is a covered security. Although
the states are preempted from regulating the sale of covered securities, the federal statute does allow the states to investigate companies
if there is a suspicion of fraud, and, if there is a finding of fraudulent